Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2)

Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 3, 2003, Pages 364-371

  Halum, Stacey L ^a   Erbe, Christy B ^a   Friedland, David R ^a   Wackym, Phillip A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MERLIN; POLYADENYLIC ACID;

ADULT; ARTICLE; BACTERIOPHAGE; CARCINOGENESIS; CASE REPORT; DNA LIBRARY; DNA MICROARRAY; DNA SEQUENCE; FEMALE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; NEURILEMOMA; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ISOLATION; SEQUENCE ANALYSIS;

EID: 0037346225     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2003.99     Document Type: Article

References (19)

1. Lanser MJ, Sussman SA, Frazer K. Epidemiology, pathogenesis, and genetics of acoustic tumors. Otolaryngol Clin North Am 1992;25:499-520.
2. Tos M, Thompsen J. Epidemiology of acoustic neuromas. J Laryngol Otol 1984;98:685-92.
3. Evans DGR, Huson SM, Donnai D, et al. A genetic study of type of neurofibromatosis: II. Guidelines for genetic counseling. J Med Genet 1992;29:847-52.
4. Welling DB. Clinical manifestations of mutations in the NF2 gene in vestibular schwannomas (acoustic neuromas). Laryngoscope 1998;108:178-89.
5. Welling DB, Akhmametyeva EM, Daniels RL, et al. Analysis of the human NF2 gene promoter and its expression. Otolaryngol Head Neck Surg 2000;123:413-8.
6. Green CD, Simons JF, Taillon BE, et al. Open-systems: panoramic views of gene expression. J Immunol Methods 2001;250:67-79.
7. Park H-J, Niedzileski AS, Wenthold RJ. Expression of the nicotinic acetylcholine receptor subunit, α9, in the guinea pig cochlea. Hear Res 1997;112:95-105.
8. Anderson AD, Troyanovskaya M, Wackym PA. Differential expression of 2-7, 9 and 2-4 nicotinic acetylcholine receptor subunit mRNA in the vestibular end organs and Scarpa's ganglia of the rat. Brain Res 1997;778:414-8.
9. Wackym PA. Perspectives on the future of temporal bone research. Am J Otol 1997;18:693-6.
10. Ruttledge MH, Andermann AA, Phelan CM, et al. Type of mutation in the NF2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 1996;59:331-42.
11. Jacoby LB, MacCollin M, Louis DN, et al. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994;3:413-9.
12. Irving RM, Harada T, Moffat DA, et al. Somatic NF2 gene mutations and growth characteristics in vestibular schwannoma. Am J Otol 1997;18:754-60.
13. Bianchi AB, Hara T, Ramesh V, et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 1994;6:185-92.
14. Sato N, Funayama N, Nagafuchi A, et al. A gene family consisting of ezrin, radixin, and moesin: its specific localization at actin filament/plasma membrane association sites. J Cell Sci 1992;103:131-43.
15. Gutmann DH, Geist RT, Xu H-M, et al. Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum Mol Genet 1998;7:335-45.
16. Morrison H, Sherman LS, Legg J, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001;15:968-80.
17. Velculescu VE, Zhang L, Vogelstein B, et al. Serial analysis of gene expression. Science (Washington DC) 1995;270:484-7.
18. Sutcliffe JG, Foye PE, Erlander MG, et al. TOGA: an automated parsing technology for analyzing expression of nearly all genes. Proc Natl Acad Sci USA 2000;97: 1976-81.
19. Lash AE, Tolstoshev CM, Wagner L, et al. SAGEmap: a public gene expression resource. Genome Res 2000;10: 1051-60.